ITEMS IN AFP WITH KEYWORD:

Dementia

Sep 15, 2019 Issue
Diagnosing Dementia and Clarifying Goals of Care [Lown Right Care: Reducing Overuse and Underuse]

A collaboration between AFP and the Lown Institute promotes a vision of delivering heath care that is based on the evidence, balanced in its approach, and focused on the patient.


May 1, 2019 Issue
Vaginitis, Coronary Artery Disease, Hypertension in Children, COPD, Alzheimer Disease [AFP Clinical Answers]

Key clinical questions and their evidence-based answers directly from the journal’s content, written by and for family physicians.


Apr 1, 2019 Issue
Palliative Care in Advanced Dementia [Curbside Consultation]

What is the best way for family physicians to determine prognosis and applicability of palliative care for patients with dementia?


Feb 1, 2019 Issue
Behavior Issues, Skin Cancer, Adolescent Depression, Prostate Cancer, Deprescribing Antipsychotics [AFP Clinical Answers]

Key clinical questions and their evidence-based answers directly from the journal’s content, written by and for family physicians.


Jan 1, 2019 Issue
Pharmacologic Interventions for Apathy in Patients with Alzheimer Disease [Cochrane for Clinicians]

Methylphenidate may improve apathy in select patients with AD (mean difference [MD] = –4.99 on the apathy evaluation scale; 95% confidence interval [CI], –9.55 to –0.43), although the clinical significance associated with these findings remains unclear and the evidence is considered low quality.


Sep 15, 2018 Issue
Deprescribing Antipsychotics for Behavioral and Psychological Symptoms of Dementia and Insomnia [Practice Guidelines]

As part of the Deprescribing Guidelines in the Elderly Project, a Canadian team consisting of two family physicians, one geriatric psychiatrist, two geriatricians, and four pharmacists has provided recommendations to guide physicians in deprescribing antipsychotics for behavioral and psychological symptoms of dementia and insomnia.


Aug 15, 2018 Issue
Medications Ineffective to Prevent Cognitive Decline or Dementia [POEMs]

None of the medications in this systematic review prevented or delayed cognitive decline, cognitive impairment, or dementia.


Jun 1, 2018 Issue
Cerebrospinal Fluid Biomarkers for Detection of Alzheimer Disease in Patients with Mild Cognitive Impairment [Cochrane for Clinicians]

There is insufficient evidence to support the routine use of cerebrospinal fluid (CSF) biomarkers for the detection of progressive dementias in patients with mild cognitive impairment (MCI). These tests carry the risk of overdiagnosis of dementia and, therefore, overtreatment.


Apr 1, 2018 Issue
Short-Term Antipsychotics for Alzheimer Disease [FPIN's Help Desk Answers]

Physicians should consider not using antipsychotics in patients with dementia. Patients with dementia, including Alzheimer disease, who are treated with antipsychotics for any length of time have a higher mortality rate than those not taking antipsychotics.


Mar 15, 2018 Issue
Evaluation of Suspected Dementia [Article]

Patients with suspected dementia can be screened in the primary care office setting with a brief screening tool. A positive screening result warrants more in-depth screening tests. Evaluation for depression, laboratory studies for possible medical conditions that affect memory, and magnetic resonance imaging of the brain should be performed if cognitive impairment is confirmed.


Pages: 1 2 3 4 5 6 Next


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now